Your browser is no longer supported. Please, upgrade your browser.
Settings
INSM Insmed Incorporated daily Stock Chart
INSM [NASD]
Insmed Incorporated
Index- P/E- EPS (ttm)-2.91 Insider Own1.20% Shs Outstand62.04M Perf Week-1.95%
Market Cap1.03B Forward P/E- EPS next Y-2.16 Insider Trans-1.33% Shs Float61.22M Perf Month-5.15%
Income-180.20M PEG- EPS next Q-0.63 Inst Own94.20% Short Float5.96% Perf Quarter-11.61%
Sales- P/S- EPS this Y-41.30% Inst Trans0.02% Short Ratio9.39 Perf Half Y12.70%
Book/sh1.96 P/B8.46 EPS next Y13.30% ROA-71.00% Target Price25.00 Perf Year46.04%
Cash/sh2.03 P/C8.18 EPS next 5Y- ROE-96.80% 52W Range10.21 - 19.35 Perf YTD25.40%
Dividend- P/FCF- EPS past 5Y0.70% ROI- 52W High-14.26% Beta0.67
Dividend %- Quick Ratio5.70 Sales past 5Y- Gross Margin- 52W Low62.49% ATR0.69
Employees161 Current Ratio5.70 Sales Q/Q- Oper. Margin- RSI (14)45.36 Volatility3.68% 3.90%
OptionableYes Debt/Eq0.00 EPS Q/Q-11.20% Profit Margin- Rel Volume1.84 Prev Close17.44
ShortableYes LT Debt/Eq0.45 EarningsAug 03 BMO Payout- Avg Volume388.75K Price16.59
Recom1.70 SMA20-3.54% SMA50-0.79% SMA2006.69% Volume716,091 Change-4.87%
Jul-11-17Initiated Robert W. Baird Outperform $23
Mar-15-16Initiated Stifel Buy $23
Nov-09-15Downgrade UBS Buy → Neutral $35 → $18
Oct-06-15Reiterated H.C. Wainwright Buy $30 → $35
Jun-09-15Initiated Citigroup Neutral $27
Mar-26-14Reiterated HC Wainwright Buy $25 → $30
Jan-06-14Reiterated UBS Buy $17.50 → $31
Nov-11-13Initiated HC Wainwright Buy $25
Jun-19-13Initiated UBS Buy $17.50
Jun-18-13Initiated UBS Buy $17.50
Sep-16-11Initiated Wedbush Outperform $15
Jul-27-17 08:00AM  Insmed to Host Second Quarter 2017 Financial Results Conference Call on Thursday, August 3, 2017 GlobeNewswire
Jul-17-17 08:30AM  Implied Volatility Surging For Insmed, Inc. (INSM) Stock Options Zacks
Jul-12-17 08:00AM  Insmed to Host Analyst and Investor Day on July 19, 2017 GlobeNewswire
Jun-27-17 08:53AM  Options Traders Expect Huge Moves in Insmed (INSM) Stock Zacks
Jun-13-17 08:00AM  Insmed to Present at the JMP Securities Life Sciences Conference GlobeNewswire
Jun-08-17 08:00AM  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
May-18-17 01:05PM  Edited Transcript of INSM earnings conference call or presentation 3-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-15-17 07:00AM  Insmed Announces Key Additions to its Executive Management Team GlobeNewswire
May-04-17 07:26PM  Edited Transcript of INSM earnings conference call or presentation 3-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-03-17 08:10AM  Insmed reports 1Q loss Associated Press
08:02AM  Insmed Reports First Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
07:15AM  Investor Network: Insmed Incorporated to Host Earnings Call Accesswire
Apr-28-17 08:46AM  Implied Volatility Surging for Insmed (INSM) Stock Options Zacks
Apr-27-17 07:00AM  Insmed to Present at the Deutsche Bank 42nd Annual Health Care Conference GlobeNewswire
Apr-26-17 07:00AM  Insmed to Host First Quarter 2017 Financial Results Conference Call on Wednesday, May 3, 2017 GlobeNewswire
Mar-21-17 08:58AM  Do Options Traders Know Something About Insmed Incorporated (INSM) Stock We Don't? Zacks -5.71%
Feb-28-17 01:04PM  INSMED INC Financials
08:00AM  Insmed to Present at the Cowen and Company 37th Annual Health Care Conference GlobeNewswire
Feb-23-17 04:21PM  Edited Transcript of INSM earnings conference call or presentation 23-Feb-17 1:30pm GMT Thomson Reuters StreetEvents
09:35AM  Insmed reports 4Q loss Associated Press
08:18AM  INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:12AM  INSMED INC Files SEC form 10-K, Annual Report
08:02AM  Insmed Reports Fourth Quarter 2016 Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q4 2016 Insmed Inc Earnings Release - Before Market Open
Feb-16-17 07:00AM  Insmed to Host Fourth Quarter and Year-end 2016 Financial Results Conference Call on Thursday, February 23, 2017 GlobeNewswire
Feb-14-17 08:05AM  Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent GlobeNewswire
Jan-17-17 05:25PM  Lifshitz & Miller Law Firm Announces Investigation of Calamos Asset Management, Inc., CDI Corp., comScore, Inc., Earthstone Energy, Inc., Heritage Oaks Bancorp, Insmed Incorporated, OCI Partners LP and Vascular Solutions, Inc. PR Newswire
Jan-04-17 08:00AM  Insmed to Present at the 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-05-16 12:12PM  Hedge Funds Sour Slightly On Insmed Incorporated (INSM), But Remain Overweight Insider Monkey
12:12PM  Hedge Funds Sour Slightly On Insmed Incorporated (INSM), But Remain Overweight at Insider Monkey
Nov-28-16 02:15PM  Insmed, Inc. :INSM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 -5.19%
Nov-14-16 08:00AM  Insmed to Participate at November Investor Conferences GlobeNewswire
Nov-04-16 03:05PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of Insmed, Inc. (INSM) on Behalf of Shareholders Business Wire +8.20%
09:17AM  Edited Transcript of INSM earnings conference call or presentation 3-Nov-16 12:30pm GMT
Nov-03-16 08:34AM  Insmed reports 3Q loss -13.74%
08:06AM  INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Office
08:03AM  INSMED INC Files SEC form 10-Q, Quarterly Report
08:02AM  Insmed Reports Third Quarter 2016 Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q3 2016 Insmed Inc Earnings Release - Before Market Open
Oct-27-16 08:00AM  Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016 GlobeNewswire
Oct-18-16 08:00AM  Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease GlobeNewswire
Oct-05-16 07:31AM  AstraZeneca licenses respiratory drug to Insmed Reuters
07:06AM  INSMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
06:55AM  Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor GlobeNewswire
Sep-27-16 08:06AM  INSMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhi
08:00AM  Insmed Appoints Roger Adsett as Chief Commercial Officer GlobeNewswire
Sep-13-16 03:19PM  Insmed, Inc. :INSM-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016
Sep-12-16 06:38PM  DEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm Accesswire +5.16%
03:00PM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Insmed Incorporated (INSM) & Lead Plaintiff Deadline - September 13, 2016 Accesswire
11:51AM  DEADLINE TOMORROW ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm Accesswire
10:36AM  DEADLINE TOMORROW: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016 - INSM GlobeNewswire
Sep-10-16 11:18PM  SEPTEMBER 13 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm Accesswire
Sep-09-16 08:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Insmed Incorporated of Class Action Lawsuit and Upcoming Deadline - INSM Accesswire -5.38%
Sep-08-16 11:24AM  5-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire
10:20AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action against Insmed Incorporated (INSM) & Lead Plaintiff Deadline - September 13, 2016 Accesswire
08:00AM  Insmed to Participate at September Investor Conferences GlobeNewswire
Sep-07-16 01:19PM  SHAREHOLDER ALERT Rosen Law Firm Reminds Insmed Incorporated Investors of Important September 13 Deadline in Class Action - INSM PR Newswire
10:25AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Insmed Incorporated of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016 INSM GlobeNewswire
Sep-02-16 10:59AM  DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm Accesswire
10:00AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Insmed Incorporated (INSM) & Lead Plaintiff Deadline - September 13, 2016 GlobeNewswire
09:50AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Insmed Incorporated of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016 Business Wire
Sep-01-16 01:39PM  APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire
12:19PM  DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Insmed Incorporated Of Upcoming Deadline GlobeNewswire
Aug-31-16 08:00AM  Insmed Announces Upcoming Presentations at European Respiratory Society 2016 International Congress GlobeNewswire
Aug-29-16 12:30PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire
10:13AM  INSM SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016 Business Wire
Aug-28-16 07:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Insmed Incorporated of Class Action Lawsuit and Upcoming Deadline INSM GlobeNewswire
Aug-24-16 07:48PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire -5.44%
09:52AM  INSM INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016 PR Newswire
Aug-19-16 11:25AM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire
10:56AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Insmed Incorporated of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016 Business Wire
Aug-18-16 03:15PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire
06:00AM  Brower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Those with Substantial Losses from Investment in Insmed Incorporated to Contact the Firm Business Wire
Aug-15-16 03:45PM  INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire +5.29%
10:48AM  INSM SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016 Business Wire
Aug-12-16 08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Insmed Incorporated of Class Action Lawsuit and Upcoming Deadline - INSM Accesswire
01:31PM  SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm Accesswire
12:31PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Insmed Incorporated INSM GlobeNewswire
Aug-11-16 02:16PM  DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire
10:17AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action against Insmed Incorporated (INSM) and Lead Plaintiff Deadline: September 13, 2016 Accesswire
Aug-10-16 12:29PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire
11:24AM  INSM INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016 GlobeNewswire
Aug-09-16 11:28AM  INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm Accesswire
Aug-08-16 04:20PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Insmed Incorporated To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit INSM GlobeNewswire
Aug-05-16 05:33PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Insmed Incorporated of Class Action Lawsuit and Upcoming Deadline - INSM Accesswire
09:30AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Insmed Incorporated of Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016 INSM GlobeNewswire
Aug-04-16 09:25AM  Insmed reports 2Q loss
08:07AM  INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:05AM  INSMED INC Files SEC form 10-Q, Quarterly Report
08:02AM  Insmed Reports Second Quarter 2016 Financial Results GlobeNewswire
Aug-03-16 10:17AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action against Insmed Incorporated (INSM) and Lead Plaintiff Deadline: September 13, 2016 Accesswire
Aug-02-16 11:52AM  IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire
07:31AM  Lifshitz & Miller Law Firm Announces Investigation of Ambac Financial Group, Inc., CBL & Associates Properties Inc., Emergent BioSolutions, Inc., Insmed Incorporated, K12 Inc., Lipocine, Inc., and Stericycle, Inc. PR Newswire
06:35AM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm Accesswire
Aug-01-16 11:08AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Insmed Incorporated of Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016 INSM Accesswire
10:40AM  IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm Accesswire
Jul-30-16 12:01AM  Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigations of; Oracle Corporation, K12 Inc., Juno Therapeutics, Inc., Albany Molecular Research Inc. and Insmed Incorporated; Encourages Long-Term Investors to Contact the Firm PR Newswire
Jul-29-16 08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Insmed Incorporated of Class Action Lawsuit and Upcoming Deadline INSM GlobeNewswire
03:29PM  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Insmed Incorporated GlobeNewswire
02:49PM  STOCK ALERT: Rosen Law Firm Reminds Insmed Incorporated Investors of Important Deadline in Class Action INSM Business Wire
Insmed Incorporated, a biopharmaceutical company, focuses on the development and commercialization of therapies for patients with rare diseases. The company's lead product candidate is ARIKAYCE or liposomal amikacin for inhalation, a formulation of amikacin that is in late-stage clinical development for adult patients with treatment refractory nontuberculous mycobacteria lung disease caused by Mycobacterium avium complex. It is also developing INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1, which has completed a Phase I clinical study for activating neutrophil serine proteases that are implicated in the pathology of chronic inflammatory lung diseases, such as non-cystic fibrosis bronchiectasis; and INS1009, an inhaled nanoparticle formulation of a treprostinil prodrug, which has completed a Phase I clinical study for treating rare pulmonary disorders, including pulmonary arterial hypertension. The company was founded in 1999 and is headquartered in Bridgewater, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pellizzari Christine AGeneral Counsel & Corp. Sec.May 31Buy14.892,70040,20330,000Jun 01 04:07 PM
Pellizzari Christine AGeneral Counsel & Corp. Sec.May 30Buy15.237,300111,17927,300Jun 01 04:07 PM
Drechsler Andrew TChief Financial OfficerMar 01Option Exercise6.6530,000199,50025,000Mar 03 04:17 PM
Drechsler Andrew TChief Financial OfficerMar 01Sale16.5120,000330,2005,000Mar 03 04:17 PM
Pellizzari Christine AGeneral Counsel & Corp. Sec.Dec 15Buy12.8910,000128,90020,000Dec 16 04:41 PM
Pellizzari Christine AGeneral Counsel & Corp. Sec.Dec 14Buy12.7210,000127,20010,000Dec 16 04:41 PM
POTTER MYRTLE SDirectorDec 14Sale12.775,00063,8450Dec 15 09:07 AM
POTTER MYRTLE SDirectorDec 13Sale12.881,46618,8865,000Dec 15 09:07 AM
Drechsler Andrew TChief Financial OfficerNov 17Option Exercise6.655,00033,2505,000Nov 18 04:08 PM
Drechsler Andrew TChief Financial OfficerNov 14Option Exercise6.7945,000305,50025,000Nov 15 05:07 PM
Drechsler Andrew TChief Financial OfficerNov 14Sale14.6745,000660,1500Nov 15 05:07 PM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.Nov 09Option Exercise6.968,00955,7438,009Nov 09 04:31 PM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.Nov 09Sale13.258,009106,1190Nov 09 04:31 PM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.Nov 07Option Exercise6.9660,765422,92437,500Nov 09 04:31 PM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.Nov 07Sale11.7860,765715,8120Nov 09 04:31 PM